Mr. Altman’s leadership roles have been in public and private organizations in which he was challenged to identify opportunities to enhance value for stakeholders and overcome impediments to success. His broad experience includes cell/gene therapy, genomics, therapeutics, contract research, and medical diagnostics. He has served as CEO, COO, VP and GM in several organizations. Most recently he led the divestment of a medical diagnostics company to LabCorp. Mr. Altman was trained as a scientist and holds a PhD in biochemistry/virology.
User's Paper Trades
You must sign up for a CEO.CA account to view paper trades.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.